APAC IPOs & Placements, Aequitas Research

Hong Jie Seow

At Aequitas we cover all IPOs and placements across Asia-Pac with a deal size of at least US$100m. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

APAC IPOs & Placements

UltraGreen.ai IPO Trading: Attractive Pricing, Strong Tailwinds

UltraGreen.ai IPO: High Growth and High Margins, Market Leader

UltraGreen.ai Pre-IPO: Strong Financials Despite Misleading Branding

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Capital Markets

<ul>
<li>
<a href="https://www.smartkarma.com/entities/ultragreen-ai-limited" target="_blank" data-smartkarma-citation="entities:46023:1" rel="noopener">UltraGreen.ai (UGAI SP)</a> raised US$400m in its Singapore IPO in December 2025.</li>
<li>Ultragreen is a global leader in Fluorescence Guided Surgery (FGS), a surgical approach that helps doctors see things inside the body that are normally invisible under regular white light.</li>
<li>In this note, we will talk about the lockup dynamics and possible placement.</li>
</ul>



UltraGreen.ai (UGAI SP) raised US$400m in its Singapore IPO in December 2025.
Ultragreen is a global leader in Fluorescence Guided Surgery (FGS), a surgical approach that helps doctors see things inside the body that are normally invisible under regular white light.
In this note, we will talk about the lockup dynamics and possible placement.


Aequitas: Ultragreen IPO Lockup Expiry - US$1.05bn Lockup Release